How molecular glues are connecting targeted protein degradation to the clinic

Targeted protein degradation is a novel and quickly expanding drug discovery strategy. It is a new way of utilizing disease-causing proteins to attack severe illnesses, which has the potential to be used among more serious illnesses, like cancer or neurodegenerative diseases.

This study from the American Chemical Society utilizes the CAS Content Collection and recent research on protein degraders to provide more nuanced insight into molecular glue as a tool for new drug discovery. It analyzes the advantages and disadvantages of molecular glue as a reference to support further research.

Read The Full Journal publication

Related CAS Insights

創薬

A review of the global efforts on COVID-19 vaccine development

March 29, 2021

Read article
創薬

ACE2という、疾病病因特定において潜在的に重要なレセプターを標的にする

December 15, 2022

Read article
創薬

ACS webinar on molecular glues and targeted protein degradation

October 12, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.